{
  "trial_id": "NCT03271762",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Primary Mitral Regurgitation grade 3+ or 4+",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients in class II to IV NYHA",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Mitral valve anatomy appropriate to MitraClip\u00ae therapy and mitral valve surgery",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Evolving endocarditis or active endocarditis or inflammatory disease in the last 3 months",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patient who cannot tolerate procedural anticoagulation or post procedural antiplatelet regimen",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation, who was planned for a MV repair but was lost to follow-up. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery.",
  "_meta": {
    "topic_id": "12",
    "trial_id": "NCT03271762",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}